Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

SELL
$4.71 - $6.66 $245,640 - $347,338
-52,153 Reduced 25.92%
149,062 $931,000
Q4 2022

Feb 13, 2023

SELL
$4.06 - $5.71 $95,824 - $134,767
-23,602 Reduced 10.5%
201,215 $937,000
Q3 2022

Nov 10, 2022

SELL
$4.67 - $7.81 $72,861 - $121,851
-15,602 Reduced 6.49%
224,817 $1.05 Million
Q2 2022

Aug 11, 2022

SELL
$5.84 - $20.02 $13,776 - $47,227
-2,359 Reduced 0.97%
240,419 $1.42 Million
Q1 2022

May 13, 2022

BUY
$13.62 - $32.45 $1.28 Million - $3.05 Million
93,844 Added 63.01%
242,778 $4.69 Million
Q4 2021

Feb 14, 2022

SELL
$32.11 - $47.16 $17.4 Million - $25.6 Million
-541,949 Reduced 78.44%
148,934 $4.87 Million
Q3 2021

Nov 12, 2021

SELL
$29.63 - $46.98 $616,155 - $976,949
-20,795 Reduced 2.92%
690,883 $28.3 Million
Q2 2021

Aug 13, 2021

BUY
$28.27 - $41.18 $20.1 Million - $29.3 Million
711,678 New
711,678 $25.6 Million

Others Institutions Holding GDRX

About GoodRx Holdings, Inc.


  • Ticker GDRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 84,394,800
  • Market Cap $375M
  • Description
  • GoodRx Holdings, Inc., through its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated pri...
More about GDRX
Track Ray Dalio's Portfolio

Track Ray Dalio Portfolio

Follow Ray Dalio (Bridgewater Associates, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.